ERYN GORMAN: Open Payments
NPI 1710430632 · CLINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 41 payments from 13 companies in 2025. Trend: 2023 $3,975 · 2024 $2,530 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $250 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| Novo Nordisk Inc | 4 | $86 |
| Xeris Pharmaceuticals, Inc. | 4 | $83 |
| Lilly USA, LLC | 4 | $69 |
| Tandem Diabetes Care, Inc. | 3 | $46 |
| Radius Health, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Insulet Corporation | 1 | $24 |
Products named: Korlym, Kerendia, t:slim X2 Insulin Pump with Control-IQ, RECORLEV, MOUNJARO, GVOKE HYPOPEN, Tymlos, JARDIANCE.
Industry payments across IN — which companies pay providers there.
